<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35349492</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>10</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>15</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2379-3708</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>7</Volume>
            <Issue>9</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>09</Day>
            </PubDate>
          </JournalIssue>
          <Title>JCI insight</Title>
          <ISOAbbreviation>JCI Insight</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A Notch/IL-21 signaling axis primes bone marrow T cell progenitor expansion.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">e157015</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1172/jci.insight.157015</ELocationID>
        <Abstract>
          <AbstractText>Long-term impairment in T cell-mediated adaptive immunity is a major clinical obstacle following treatment of blood disorders with hematopoietic stem cell transplantation. Although T cell development in the thymus has been extensively characterized, there are significant gaps in our understanding of prethymic processes that influence early T cell potential. We have uncovered a Notch/IL-21 signaling axis in bone marrow common lymphoid progenitor (CLP) cells. IL-21 receptor expression was driven by Notch activation in CLPs, and in vivo treatment with IL-21 induced Notch-dependent CLP proliferation. Taking advantage of this potentially novel signaling axis, we generated T cell progenitors ex vivo, which improved repopulation of the thymus and peripheral lymphoid organs of mice in an allogeneic transplant model. Importantly, Notch and IL-21 activation were equally effective in the priming and expansion of human cord blood cells toward the T cell fate, confirming the translational potential of the combined treatment.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Sottoriva</LastName>
            <ForeName>Kilian</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology and Regenerative Medicine and.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Paik</LastName>
            <ForeName>Na Yoon</ForeName>
            <Initials>NY</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology and Regenerative Medicine and.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>White</LastName>
            <ForeName>Zachary</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Microbiology and Immunology, University of Illinois at Chicago College of Medicine, Chicago, Illinois, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bandara</LastName>
            <ForeName>Thilinie</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology and Regenerative Medicine and.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shao</LastName>
            <ForeName>Lijian</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology and Regenerative Medicine and.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sano</LastName>
            <ForeName>Teruyuki</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Microbiology and Immunology, University of Illinois at Chicago College of Medicine, Chicago, Illinois, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pajcini</LastName>
            <ForeName>Kostandin V</ForeName>
            <Initials>KV</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology and Regenerative Medicine and.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R01 HL134971</GrantID>
            <Acronym>HL</Acronym>
            <Agency>NHLBI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 HL151720</GrantID>
            <Acronym>HL</Acronym>
            <Agency>NHLBI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>T32 HL007829</GrantID>
            <Acronym>HL</Acronym>
            <Agency>NHLBI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>09</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>JCI Insight</MedlineTA>
        <NlmUniqueID>101676073</NlmUniqueID>
        <ISSNLinking>2379-3708</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007378">Interleukins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>MKM3CA6LT1</RegistryNumber>
          <NameOfSubstance UI="C416243">interleukin-21</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001853" MajorTopicYN="N">Bone Marrow</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006412" MajorTopicYN="Y">Hematopoietic Stem Cells</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007378" MajorTopicYN="N">Interleukins</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013601" MajorTopicYN="Y">T-Lymphocytes</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Bone marrow transplantation</Keyword>
        <Keyword MajorTopicYN="N">Hematology</Keyword>
        <Keyword MajorTopicYN="N">T cell development</Keyword>
        <Keyword MajorTopicYN="N">Transplantation</Keyword>
      </KeywordList>
      <CoiStatement><b>Conflict of interest:</b> The authors have declared that no conflict of interest exists.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>29</Day>
          <Hour>17</Hour>
          <Minute>12</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35349492</ArticleId>
        <ArticleId IdType="pmc">PMC9090257</ArticleId>
        <ArticleId IdType="doi">10.1172/jci.insight.157015</ArticleId>
        <ArticleId IdType="pii">157015</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Themeli M, et al.  New cell sources for T cell engineering and adoptive immunotherapy. Cell Stem Cell. 2015;16(4):357–366. doi: 10.1016/j.stem.2015.03.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.stem.2015.03.011</ArticleId>
            <ArticleId IdType="pmc">PMC5611846</ArticleId>
            <ArticleId IdType="pubmed">25842976</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zakrzewski JL, et al.  Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors. Nat Biotechnol. 2008;26(4):453–461. doi: 10.1038/nbt1395.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nbt1395</ArticleId>
            <ArticleId IdType="pmc">PMC2731996</ArticleId>
            <ArticleId IdType="pubmed">18376399</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shukla S, et al.  Progenitor T-cell differentiation from hematopoietic stem cells using Delta-like-4 and VCAM-1. Nat Methods. 2017;14(5):531–538. doi: 10.1038/nmeth.4258.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nmeth.4258</ArticleId>
            <ArticleId IdType="pubmed">28394335</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith M, et al.  Posttransplant chimeric antigen receptor therapy. Blood. 2018;131(10):1045–1052. doi: 10.1182/blood-2017-08-752121.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2017-08-752121</ArticleId>
            <ArticleId IdType="pmc">PMC5865610</ArticleId>
            <ArticleId IdType="pubmed">29358181</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Menon T, et al.  Lymphoid regeneration from gene-corrected SCID-X1 subject-derived iPSCs. Cell Stem Cell. 2015;16(4):367–372. doi: 10.1016/j.stem.2015.02.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.stem.2015.02.005</ArticleId>
            <ArticleId IdType="pmc">PMC4545662</ArticleId>
            <ArticleId IdType="pubmed">25772073</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iriguchi S, et al.  A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy. Nat Commun. 2021;12(1):430.  doi: 10.1038/s41467-020-20658-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41467-020-20658-3</ArticleId>
            <ArticleId IdType="pmc">PMC7814014</ArticleId>
            <ArticleId IdType="pubmed">33462228</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reimann C, et al.  Human T-lymphoid progenitors generated in a feeder-cell-free Delta-like-4 culture system promote T-cell reconstitution in NOD/SCID/γc(-/-) mice. Stem Cells. 2012;30(8):1771–1780. doi: 10.1002/stem.1145.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/stem.1145</ArticleId>
            <ArticleId IdType="pmc">PMC3531890</ArticleId>
            <ArticleId IdType="pubmed">22689616</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dai X, et al.  Standardizing CAR-T therapy: getting it scaled up. Biotechnol Adv. 2019;37(1):239–245. doi: 10.1016/j.biotechadv.2018.12.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biotechadv.2018.12.002</ArticleId>
            <ArticleId IdType="pubmed">30543841</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sambandam A, et al.  Notch signaling controls the generation and differentiation of early T lineage progenitors. Nat Immunol. 2005;6(7):663–670. doi: 10.1038/ni1216.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ni1216</ArticleId>
            <ArticleId IdType="pubmed">15951813</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tan JB, et al.  Requirement for Notch1 signals at sequential early stages of intrathymic T cell development. Nat Immunol. 2005;6(7):671–679. doi: 10.1038/ni1217.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ni1217</ArticleId>
            <ArticleId IdType="pubmed">15951812</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Radtke F, et al.  Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity. 1999;10(5):547–558. doi: 10.1016/S1074-7613(00)80054-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1074-7613(00)80054-0</ArticleId>
            <ArticleId IdType="pubmed">10367900</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kumar BV, et al.  Human T cell development, localization, and function throughout life. Immunity. 2018;48(2):202–213. doi: 10.1016/j.immuni.2018.01.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.immuni.2018.01.007</ArticleId>
            <ArticleId IdType="pmc">PMC5826622</ArticleId>
            <ArticleId IdType="pubmed">29466753</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rothenberg EV. T cell lineage commitment: identity and renunciation. J Immunol. 2011;186(12):6649–6655. doi: 10.4049/jimmunol.1003703.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.1003703</ArticleId>
            <ArticleId IdType="pmc">PMC3111953</ArticleId>
            <ArticleId IdType="pubmed">21646301</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yui MA, et al.  Fine-scale staging of T cell lineage commitment in adult mouse thymus. J Immunol. 2010;185(1):284–293. doi: 10.4049/jimmunol.1000679.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.1000679</ArticleId>
            <ArticleId IdType="pmc">PMC4091773</ArticleId>
            <ArticleId IdType="pubmed">20543111</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yui MA, Rothenberg EV. Developmental gene networks: a triathlon on the course to T cell identity. Nat Rev Immunol. 2014;14(8):529–545. doi: 10.1038/nri3702.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nri3702</ArticleId>
            <ArticleId IdType="pmc">PMC4153685</ArticleId>
            <ArticleId IdType="pubmed">25060579</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Amsen D, et al.  Notch in T cell differentiation: all things considered. Trends Immunol. 2015;36(12):802–814. doi: 10.1016/j.it.2015.10.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.it.2015.10.007</ArticleId>
            <ArticleId IdType="pubmed">26617322</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hosokawa H, Rothenberg EV. Cytokines, transcription factors, and the initiation of T-cell development. Cold Spring Harb Perspect Biol. 2018;10(5):a028621.  doi: 10.1101/cshperspect.a028621.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/cshperspect.a028621</ArticleId>
            <ArticleId IdType="pmc">PMC5876153</ArticleId>
            <ArticleId IdType="pubmed">28716889</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hozumi K, et al.  Delta-like 4 is indispensable in thymic environment specific for T cell development. J Exp Med. 2008;205(11):2507–2513. doi: 10.1084/jem.20080134.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.20080134</ArticleId>
            <ArticleId IdType="pmc">PMC2571926</ArticleId>
            <ArticleId IdType="pubmed">18824583</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Steinbuck MP, Winandy S. A review of Notch processing with new insights into ligand-independent Notch signaling in T-cells. Front Immunol. 2018;9:1230.  doi: 10.3389/fimmu.2018.01230.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2018.01230</ArticleId>
            <ArticleId IdType="pmc">PMC5992298</ArticleId>
            <ArticleId IdType="pubmed">29910816</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kopan R, Ilagan MXG. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell. 2009;137(2):216–233. doi: 10.1016/j.cell.2009.03.045.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2009.03.045</ArticleId>
            <ArticleId IdType="pmc">PMC2827930</ArticleId>
            <ArticleId IdType="pubmed">19379690</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bray SJ. Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol. 2006;7(9):678–689. doi: 10.1038/nrm2009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrm2009</ArticleId>
            <ArticleId IdType="pubmed">16921404</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mercher T, et al.  Notch signaling specifies megakaryocyte development from hematopoietic stem cells. Cell Stem Cell. 2008;3(3):314–326. doi: 10.1016/j.stem.2008.07.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.stem.2008.07.010</ArticleId>
            <ArticleId IdType="pmc">PMC3970322</ArticleId>
            <ArticleId IdType="pubmed">18786418</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cichocki F, et al.  Cutting edge: microRNA-181 promotes human NK cell development by regulating Notch signaling. J Immunol. 2011;187(12):6171–6175. doi: 10.4049/jimmunol.1100835.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.1100835</ArticleId>
            <ArticleId IdType="pmc">PMC3237765</ArticleId>
            <ArticleId IdType="pubmed">22084432</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kumano K, et al.  Notch1 but not Notch2 is essential for generating hematopoietic stem cells from endothelial cells. Immunity. 2003;18(5):699–711. doi: 10.1016/S1074-7613(03)00117-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1074-7613(03)00117-1</ArticleId>
            <ArticleId IdType="pubmed">12753746</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gerhardt DM, et al.  The Notch1 transcriptional activation domain is required for development and reveals a novel role for Notch1 signaling in fetal hematopoietic stem cells. Genes Dev. 2014;28(6):576–593. doi: 10.1101/gad.227496.113.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/gad.227496.113</ArticleId>
            <ArticleId IdType="pmc">PMC3967047</ArticleId>
            <ArticleId IdType="pubmed">24637115</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sottoriva K, Pajcini KV. Notch signaling in the bone marrow lymphopoietic niche. Front Immunol. 2021;12:3059. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8355626</ArticleId>
            <ArticleId IdType="pubmed">34394130</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taqvi S, et al.  Biomaterial-based Notch signaling for the differentiation of hematopoietic stem cells into T cells. J Biomed Mater Res A. 2006;79(3):689–697.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16845670</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Awong G, et al.  Characterization in vitro and engraftment potential in vivo of human progenitor T cells generated from hematopoietic stem cells. Blood. 2009;114(5):972–982. doi: 10.1182/blood-2008-10-187013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2008-10-187013</ArticleId>
            <ArticleId IdType="pubmed">19491395</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu VWC, et al.  Specific bone cells produce DLL4 to generate thymus-seeding progenitors from bone marrow. J Exp Med. 2015;212(5):759–774. doi: 10.1084/jem.20141843.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.20141843</ArticleId>
            <ArticleId IdType="pmc">PMC4419348</ArticleId>
            <ArticleId IdType="pubmed">25918341</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koo BK, et al.  Mind bomb 1 is essential for generating functional Notch ligands to activate Notch. Development. 2005;132(15):3459–3470. doi: 10.1242/dev.01922.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.01922</ArticleId>
            <ArticleId IdType="pubmed">16000382</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shao L, et al.  A Tie2-Notch1 signaling axis regulates regeneration of the endothelial bone marrow niche. Haematologica. 2019;104(11):2164–2177. doi: 10.3324/haematol.2018.208660.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3324/haematol.2018.208660</ArticleId>
            <ArticleId IdType="pmc">PMC6821596</ArticleId>
            <ArticleId IdType="pubmed">30923091</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yao D, et al.  Protein O-fucosyltransferase 1 (Pofut1) regulates lymphoid and myeloid homeostasis through modulation of Notch receptor ligand interactions. Blood. 2011;117(21):5652–5662. doi: 10.1182/blood-2010-12-326074.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2010-12-326074</ArticleId>
            <ArticleId IdType="pmc">PMC3110024</ArticleId>
            <ArticleId IdType="pubmed">21464368</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen ELY, et al.  RBPJ-dependent Notch signaling initiates the T cell program in a subset of thymus-seeding progenitors. Nat Immunol. 2019;20(11):1456–1468. doi: 10.1038/s41590-019-0518-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41590-019-0518-7</ArticleId>
            <ArticleId IdType="pmc">PMC6858571</ArticleId>
            <ArticleId IdType="pubmed">31636466</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Van Epps HL. Bringing order to early B cell chaos. J Exp Med. 2006;203(6):1389.  doi: 10.1084/jem.2036fta.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.2036fta</ArticleId>
            <ArticleId IdType="pmc">PMC2118322</ArticleId>
            <ArticleId IdType="pubmed">16823946</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fathman JW, et al.  Identification of the earliest natural killer cell-committed progenitor in murine bone marrow. Blood. 2011;118(20):5439–5447. doi: 10.1182/blood-2011-04-348912.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2011-04-348912</ArticleId>
            <ArticleId IdType="pmc">PMC3217348</ArticleId>
            <ArticleId IdType="pubmed">21931117</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miyazaki M, et al.  Thymocyte proliferation induced by pre-T cell receptor signaling is maintained through polycomb gene product Bmi-1-mediated Cdkn2a repression. Immunity. 2008;28(2):231–245. doi: 10.1016/j.immuni.2007.12.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.immuni.2007.12.013</ArticleId>
            <ArticleId IdType="pubmed">18275833</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Inlay MA, et al.  Ly6d marks the earliest stage of B-cell specification and identifies the branchpoint between B-cell and T-cell development. Genes Dev. 2009;23(20):2376–2381. doi: 10.1101/gad.1836009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/gad.1836009</ArticleId>
            <ArticleId IdType="pmc">PMC2764492</ArticleId>
            <ArticleId IdType="pubmed">19833765</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hu Y, et al.  Deptor is a direct Notch1 target that promotes cell proliferation and survival in T-cell leukemia. Oncogene. 2017;36(8):1038–1047. doi: 10.1038/onc.2016.275.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/onc.2016.275</ArticleId>
            <ArticleId IdType="pubmed">27593934</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rochman Y, et al.  New insights into the regulation of T cells by γc family cytokines. Nat Rev Immunol. 2009;9(7):480–490. doi: 10.1038/nri2580.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nri2580</ArticleId>
            <ArticleId IdType="pmc">PMC2814538</ArticleId>
            <ArticleId IdType="pubmed">19543225</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou L, et al.  IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol. 2007;8(9):967–974. doi: 10.1038/ni1488.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ni1488</ArticleId>
            <ArticleId IdType="pubmed">17581537</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diehl SA, et al.  STAT3-mediated up-regulation of BLIMP1 Is coordinated with BCL6 down-regulation to control human plasma cell differentiation. J Immunol. 2008;180(7):4805–4815. doi: 10.4049/jimmunol.180.7.4805.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.180.7.4805</ArticleId>
            <ArticleId IdType="pmc">PMC2396731</ArticleId>
            <ArticleId IdType="pubmed">18354204</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nurieva RI, et al.  Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity. 2008;29(1):138–149. doi: 10.1016/j.immuni.2008.05.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.immuni.2008.05.009</ArticleId>
            <ArticleId IdType="pmc">PMC2556461</ArticleId>
            <ArticleId IdType="pubmed">18599325</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vogelzang A, et al.  A fundamental role for interleukin-21 in the generation of T follicular helper cells. Immunity. 2008;29(1):127–137. doi: 10.1016/j.immuni.2008.06.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.immuni.2008.06.001</ArticleId>
            <ArticleId IdType="pubmed">18602282</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nurieva R, et al.  Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature. 2007;448(7152):480–483. doi: 10.1038/nature05969.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature05969</ArticleId>
            <ArticleId IdType="pubmed">17581589</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Korn T, et al.  IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature. 2007;448(7152):484–487. doi: 10.1038/nature05970.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature05970</ArticleId>
            <ArticleId IdType="pmc">PMC3805028</ArticleId>
            <ArticleId IdType="pubmed">17581588</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fröhlich A, et al.  IL-21R on T cells is critical for sustained functionality and control of chronic viral infection. Science. 2009;324(5934):1576–1580. doi: 10.1126/science.1172815.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1172815</ArticleId>
            <ArticleId IdType="pubmed">19478140</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kotlarz D, et al.  Loss-of-function mutations in the IL-21 receptor gene cause a primary immunodeficiency syndrome. J Exp Med. 2013;210(3):433–443. doi: 10.1084/jem.20111229.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.20111229</ArticleId>
            <ArticleId IdType="pmc">PMC3600901</ArticleId>
            <ArticleId IdType="pubmed">23440042</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ryan RJH, et al.  A B cell regulome links notch to downstream oncogenic pathways in small B cell lymphomas. Cell Rep. 2017;21(3):784–797. doi: 10.1016/j.celrep.2017.09.066.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2017.09.066</ArticleId>
            <ArticleId IdType="pmc">PMC5687286</ArticleId>
            <ArticleId IdType="pubmed">29045844</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Messeguer X, et al.  PROMO: detection of known transcription regulatory elements using species-tailored searches. Bioinformatics. 2002;18(2):333–334. doi: 10.1093/bioinformatics/18.2.333.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/bioinformatics/18.2.333</ArticleId>
            <ArticleId IdType="pubmed">11847087</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Farré D, et al.  Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN. Nucleic Acids Res. 2003;31(13):3651–3653. doi: 10.1093/nar/gkg605.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/nar/gkg605</ArticleId>
            <ArticleId IdType="pmc">PMC169011</ArticleId>
            <ArticleId IdType="pubmed">12824386</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rafei M, et al.  Interleukin-21 accelerates thymic recovery from glucocorticoïd-induced atrophy. PLoS One. 2013;8(9):e72801.  doi: 10.1371/journal.pone.0072801.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0072801</ArticleId>
            <ArticleId IdType="pmc">PMC3759406</ArticleId>
            <ArticleId IdType="pubmed">24023776</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Holmes R, Zuñiga-Pflücker JC. The OP9-DL1 system: generation of T-lymphocytes from embryonic or hematopoietic stem cells in vitro. Cold Spring Harb Protoc. 2009;4(2):pdb.prot5156. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20147086</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zeng R, et al.  The molecular basis of IL-21-mediated proliferation. Blood. 2007;109(10):4135–4142. doi: 10.1182/blood-2006-10-054973.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2006-10-054973</ArticleId>
            <ArticleId IdType="pmc">PMC1885510</ArticleId>
            <ArticleId IdType="pubmed">17234735</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ogilvy S, et al.  Promoter elements of vav drive transgene expression in vivo throughout the hematopoietic compartment. Blood. 1999;94(6):1855–1863.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10477714</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oh P, et al.  In vivo mapping of notch pathway activity in normal and stress hematopoiesis. Cell Stem Cell. 2013;13(2):190–204. doi: 10.1016/j.stem.2013.05.015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.stem.2013.05.015</ArticleId>
            <ArticleId IdType="pmc">PMC3902172</ArticleId>
            <ArticleId IdType="pubmed">23791481</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Varnum-Finney B, et al.  Notch2 governs the rate of generation of mouse long- and short-term repopulating stem cells. J Clin Invest. 2011;121(3):1207–1216. doi: 10.1172/JCI43868.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI43868</ArticleId>
            <ArticleId IdType="pmc">PMC3049401</ArticleId>
            <ArticleId IdType="pubmed">21285514</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leonard WJ, Wan CK. IL-21 signaling in immunity. F1000Res. 2016;5:224.  doi: 10.12688/f1000research.7634.1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.12688/f1000research.7634.1</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mueller SN, Mackay LK. Tissue-resident memory T cells: local specialists in immune defence. Nat Rev Immunol. 2016;16(2):79–89. doi: 10.1038/nri.2015.3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nri.2015.3</ArticleId>
            <ArticleId IdType="pubmed">26688350</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Steinbach K, et al.  Resident-memory T cells in tissue-restricted immune responses: for better or worse? Front Immunol. 2018;9:2827.  doi: 10.3389/fimmu.2018.02827.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2018.02827</ArticleId>
            <ArticleId IdType="pmc">PMC6284001</ArticleId>
            <ArticleId IdType="pubmed">30555489</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mackay LK, et al.  Cutting edge: CD69 interference with sphingosine-1-phosphate receptor function regulates peripheral T cell retention. J Immunol. 2015;194(5):2059–2063. doi: 10.4049/jimmunol.1402256.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.1402256</ArticleId>
            <ArticleId IdType="pubmed">25624457</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rettig MP, et al.  Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4. Leukemia. 2012;26(1):34–53. doi: 10.1038/leu.2011.197.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/leu.2011.197</ArticleId>
            <ArticleId IdType="pmc">PMC3514440</ArticleId>
            <ArticleId IdType="pubmed">21886173</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ozaki K, et al.  A critical role for IL-21 in regulating immunoglobulin production. Science. 2002;298(5598):1630–1634. doi: 10.1126/science.1077002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1077002</ArticleId>
            <ArticleId IdType="pubmed">12446913</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zakrzewski JL, et al.  Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantation. Nat Med. 2006;12(9):1039–1047. doi: 10.1038/nm1463.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm1463</ArticleId>
            <ArticleId IdType="pubmed">16936725</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zlotoff DA, et al.  Delivery of progenitors to the thymus limits T-lineage reconstitution after bone marrow transplantation. Blood. 2011;118(7):1962–1970. doi: 10.1182/blood-2010-12-324954.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2010-12-324954</ArticleId>
            <ArticleId IdType="pmc">PMC3158723</ArticleId>
            <ArticleId IdType="pubmed">21659540</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shale M, et al.  CD4(+) T-cell subsets in intestinal inflammation. Immunol Rev. 2013;252(1):164–182. doi: 10.1111/imr.12039.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/imr.12039</ArticleId>
            <ArticleId IdType="pmc">PMC3736165</ArticleId>
            <ArticleId IdType="pubmed">23405904</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maloy KJ, Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature. 2011;474(7351):298–306. doi: 10.1038/nature10208.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature10208</ArticleId>
            <ArticleId IdType="pubmed">21677746</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saleh M, Elson CO. Experimental inflammatory bowel disease: insights into the host-microbiota dialog. Immunity. 2011;34(3):293–302. doi: 10.1016/j.immuni.2011.03.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.immuni.2011.03.008</ArticleId>
            <ArticleId IdType="pmc">PMC3108903</ArticleId>
            <ArticleId IdType="pubmed">21435584</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weaver CT, et al.  The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin. Annu Rev Pathol. 2013;8:477–512. doi: 10.1146/annurev-pathol-011110-130318.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev-pathol-011110-130318</ArticleId>
            <ArticleId IdType="pmc">PMC3965671</ArticleId>
            <ArticleId IdType="pubmed">23157335</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Izcue A, et al.  Regulatory lymphocytes and intestinal inflammation. Annu Rev Immunol. 2009;27:313–338. doi: 10.1146/annurev.immunol.021908.132657.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev.immunol.021908.132657</ArticleId>
            <ArticleId IdType="pubmed">19302043</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schmitt EG, Williams CB. Generation and function of induced regulatory T cells. Front Immunol. 2013;4:152. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3685796</ArticleId>
            <ArticleId IdType="pubmed">23801990</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Curotto de Lafaille MA, Lafaille JJ. Natural and adaptive Foxp3+ regulatory T cells: more of the same or a division of labor? Immunity. 2009;30(5):626–635. doi: 10.1016/j.immuni.2009.05.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.immuni.2009.05.002</ArticleId>
            <ArticleId IdType="pubmed">19464985</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sonderegger I, et al.  IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo. Eur J Immunol. 2008;38(7):1833–1838. doi: 10.1002/eji.200838511.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/eji.200838511</ArticleId>
            <ArticleId IdType="pubmed">18546146</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pott J, Stockinger S. Type I and III interferon in the gut: tight balance between host protection and immunopathology. Front Immunol. 2017;8:1. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5241319</ArticleId>
            <ArticleId IdType="pubmed">28149297</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nava P, et al.  Interferon-gamma regulates intestinal epithelial homeostasis through converging beta-catenin signaling pathways. Immunity. 2010;32(3):392–402. doi: 10.1016/j.immuni.2010.03.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.immuni.2010.03.001</ArticleId>
            <ArticleId IdType="pmc">PMC2859189</ArticleId>
            <ArticleId IdType="pubmed">20303298</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Farin HF, et al.  Paneth cell extrusion and release of antimicrobial products is directly controlled by immune cell-derived IFN-γ. J Exp Med. 2014;211(7):1393–1405. doi: 10.1084/jem.20130753.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.20130753</ArticleId>
            <ArticleId IdType="pmc">PMC4076587</ArticleId>
            <ArticleId IdType="pubmed">24980747</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schulz SM, et al.  IL-17A is produced by Th17, γδ T cells and other CD4- lymphocytes during infection with Salmonella enterica serovar Enteritidis and has a mild effect in bacterial clearance. Int Immunol. 2008;20(9):1129–1138. doi: 10.1093/intimm/dxn069.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/intimm/dxn069</ArticleId>
            <ArticleId IdType="pubmed">18599501</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Douzandeh-Mobarrez B, Kariminik A. Gut microbiota and IL-17A: physiological and pathological responses. Probiotics Antimicrob Proteins. 2019;11(1):1–10. doi: 10.1007/s12602-017-9329-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12602-017-9329-z</ArticleId>
            <ArticleId IdType="pubmed">28921400</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sano T, et al.  An IL-23R/IL-22 circuit regulates epithelial serum amyloid A to promote local effector Th17 responses. Cell. 2015;163(2):381–393. doi: 10.1016/j.cell.2015.08.061.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2015.08.061</ArticleId>
            <ArticleId IdType="pmc">PMC4621768</ArticleId>
            <ArticleId IdType="pubmed">26411290</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Smedt M, et al.  T-lymphoid differentiation potential measured in vitro is higher in CD34+CD38-/lo hematopoietic stem cells from umbilical cord blood than from bone marrow and is an intrinsic property of the cells. Haematologica. 2011;96(5):646–654. doi: 10.3324/haematol.2010.036343.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3324/haematol.2010.036343</ArticleId>
            <ArticleId IdType="pmc">PMC3084910</ArticleId>
            <ArticleId IdType="pubmed">21330325</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thomas ED, et al.  Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N Engl J Med. 1957;257(11):491–496. doi: 10.1056/NEJM195709122571102.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJM195709122571102</ArticleId>
            <ArticleId IdType="pubmed">13464965</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Storek J, et al.  Reconstitution of the immune system after hematopoietic stem cell transplantation in humans. Semin Immunopathol. 2008;30(4):425–437. doi: 10.1007/s00281-008-0132-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00281-008-0132-5</ArticleId>
            <ArticleId IdType="pubmed">18949477</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chaudhry MS, et al.  Immune reconstitution after allogeneic hematopoietic stem cell transplantation: time to T up the thymus. J Immunol. 2017;198(1):40–46. doi: 10.4049/jimmunol.1601100.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.1601100</ArticleId>
            <ArticleId IdType="pubmed">27994167</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wilke C, et al.  Marrow damage and hematopoietic recovery following allogeneic bone marrow transplantation for acute leukemias: effect of radiation dose and conditioning regimen. Radiother Oncol. 2016;118(1):65–71. doi: 10.1016/j.radonc.2015.11.012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.radonc.2015.11.012</ArticleId>
            <ArticleId IdType="pmc">PMC4764403</ArticleId>
            <ArticleId IdType="pubmed">26653357</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krenger W, et al.  Thymic T-cell development in allogeneic stem cell transplantation. Blood. 2011;117(25):6768–6776. doi: 10.1182/blood-2011-02-334623.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2011-02-334623</ArticleId>
            <ArticleId IdType="pmc">PMC3128475</ArticleId>
            <ArticleId IdType="pubmed">21427289</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Storek J, et al.  Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts. Am J Hematol. 1997;54(2):131–138. doi: 10.1002/(SICI)1096-8652(199702)54:2&lt;131::AID-AJH6&gt;3.0.CO;2-Y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/(SICI)1096-8652(199702)54:2&lt;131::AID-AJH6&gt;3.0.CO;2-Y</ArticleId>
            <ArticleId IdType="pubmed">9034287</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crawley AM, et al.  Jak/STAT and PI3K signaling pathways have both common and distinct roles in IL-7-mediated activities in human CD8+ T cells. J Leukoc Biol. 2014;95(1):117–127. doi: 10.1189/jlb.0313122.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1189/jlb.0313122</ArticleId>
            <ArticleId IdType="pubmed">24072878</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alpdogan O, et al.  Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease. Blood. 2001;98(7):2256–2265. doi: 10.1182/blood.V98.7.2256.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood.V98.7.2256</ArticleId>
            <ArticleId IdType="pubmed">11568014</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Min D, et al.  Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation. Blood. 2002;99(12):4592–4600. doi: 10.1182/blood.V99.12.4592.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood.V99.12.4592</ArticleId>
            <ArticleId IdType="pubmed">12036893</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dudakov JA, et al.  Interleukin-22: immunobiology and pathology. Annu Rev Immunol. 2015;33:747–785. doi: 10.1146/annurev-immunol-032414-112123.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev-immunol-032414-112123</ArticleId>
            <ArticleId IdType="pmc">PMC4407497</ArticleId>
            <ArticleId IdType="pubmed">25706098</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang SL, et al.  Chemokine treatment rescues profound T-lineage progenitor homing defect after bone marrow transplant conditioning in mice. Blood. 2014;124(2):296–304. doi: 10.1182/blood-2014-01-552794.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2014-01-552794</ArticleId>
            <ArticleId IdType="pmc">PMC4093685</ArticleId>
            <ArticleId IdType="pubmed">24876562</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mackall CL, et al.  Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. Blood. 1997;89(10):3700–3707.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9160675</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Awong G, et al.  Human proT-cells generated in vitro facilitate hematopoietic stem cell-derived T-lymphopoiesis in vivo and restore thymic architecture. Blood. 2013;122(26):4210–4219. doi: 10.1182/blood-2012-12-472803.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2012-12-472803</ArticleId>
            <ArticleId IdType="pmc">PMC5527400</ArticleId>
            <ArticleId IdType="pubmed">24215033</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Simons L, et al.  Concise review: boosting T-cell reconstitution following allogeneic transplantation—current concepts and future perspectives. Stem Cells Transl Med. 2019;8(7):650–657. doi: 10.1002/sctm.18-0248.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/sctm.18-0248</ArticleId>
            <ArticleId IdType="pmc">PMC6591542</ArticleId>
            <ArticleId IdType="pubmed">30887712</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang H, et al.  Distinct roles of IL-7 and stem cell factor in the OP9-DL1 T-cell differentiation culture system. Exp Hematol. 2006;34(12):1730–1740. doi: 10.1016/j.exphem.2006.08.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.exphem.2006.08.001</ArticleId>
            <ArticleId IdType="pmc">PMC1762031</ArticleId>
            <ArticleId IdType="pubmed">17157170</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elsaesser H, et al.  IL-21 is required to control chronic viral infection. Science. 2009;324(5934):1569–1572. doi: 10.1126/science.1174182.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1174182</ArticleId>
            <ArticleId IdType="pmc">PMC2830017</ArticleId>
            <ArticleId IdType="pubmed">19423777</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Solaymani-Mohammadi S, et al.  Interleukin (IL)-21 in inflammation and immunity during parasitic diseases. Front Cell Infect Microbiol. 2019;9:401.  doi: 10.3389/fcimb.2019.00401.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fcimb.2019.00401</ArticleId>
            <ArticleId IdType="pmc">PMC6904299</ArticleId>
            <ArticleId IdType="pubmed">31867283</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moretto MM, et al.  Complex and multilayered role of IL-21 signaling during thymic development. J Immunol. 2019;203(5):1242–1251. doi: 10.4049/jimmunol.1800743.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.1800743</ArticleId>
            <ArticleId IdType="pmc">PMC6702097</ArticleId>
            <ArticleId IdType="pubmed">31341076</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Villegas JA, et al.  Cultured human thymic-derived cells display medullary thymic epithelial cell phenotype and functionality. Front Immunol. 2018;9:1663.  doi: 10.3389/fimmu.2018.01663.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2018.01663</ArticleId>
            <ArticleId IdType="pmc">PMC6064927</ArticleId>
            <ArticleId IdType="pubmed">30083154</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tormo A, et al.  Interleukin-21 promotes thymopoiesis recovery following hematopoietic stem cell transplantation. J Hematol Oncol. 2017;10(1):120.  doi: 10.1186/s13045-017-0490-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13045-017-0490-3</ArticleId>
            <ArticleId IdType="pmc">PMC5471903</ArticleId>
            <ArticleId IdType="pubmed">28615039</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ueda M, et al.  Expression of functional interleukin-21 receptor on adult T-cell leukaemia cells. Br J Haematol. 2005;128(2):169–176. doi: 10.1111/j.1365-2141.2004.05255.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2141.2004.05255.x</ArticleId>
            <ArticleId IdType="pubmed">15638850</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bard JD, et al.  IL-21 contributes to JAK3/STAT3 activation and promotes cell growth in ALK-positive anaplastic large cell lymphoma. Am J Pathol. 2009;175(2):825–834. doi: 10.2353/ajpath.2009.080982.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2353/ajpath.2009.080982</ArticleId>
            <ArticleId IdType="pmc">PMC2716977</ArticleId>
            <ArticleId IdType="pubmed">19608866</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scheeren FA, et al.  IL-21 is expressed in Hodgkin lymphoma and activates STAT5: evidence that activated STAT5 is required for Hodgkin lymphomagenesis. Blood. 2008;111(9):4706–4715. doi: 10.1182/blood-2007-08-105643.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2007-08-105643</ArticleId>
            <ArticleId IdType="pmc">PMC2343600</ArticleId>
            <ArticleId IdType="pubmed">18296629</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ménoret E, et al.  IL-21 stimulates human myeloma cell growth through an autocrine IGF-1 loop. J Immunol. 2008;181(10):6837–6842. doi: 10.4049/jimmunol.181.10.6837.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.181.10.6837</ArticleId>
            <ArticleId IdType="pubmed">18981102</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brenne AT, et al.  Interleukin-21 is a growth and survival factor for human myeloma cells. Blood. 2002;99(10):3756–3762. doi: 10.1182/blood.V99.10.3756.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood.V99.10.3756</ArticleId>
            <ArticleId IdType="pubmed">11986233</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hodge LS, et al.  IL-21 in the bone marrow microenvironment contributes to IgM secretion and proliferation of malignant cells in Waldenstrom macroglobulinemia. Blood. 2012;120(18):3774–3782. doi: 10.1182/blood-2012-03-419440.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2012-03-419440</ArticleId>
            <ArticleId IdType="pubmed">22976953</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Croce M, et al.  IL-21: a pleiotropic cytokine with potential applications in oncology. J Immunol Res. 2015;2015:696578. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4413888</ArticleId>
            <ArticleId IdType="pubmed">25961061</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hippen KL, et al.  Blocking IL-21 signaling ameliorates xenogeneic GVHD induced by human lymphocytes. Blood. 2012;119(2):619–628. doi: 10.1182/blood-2011-07-368027.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2011-07-368027</ArticleId>
            <ArticleId IdType="pmc">PMC3257019</ArticleId>
            <ArticleId IdType="pubmed">22077059</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hanash AM, et al.  Abrogation of donor T-cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD from GVL. Blood. 2011;118(2):446–455. doi: 10.1182/blood-2010-07-294785.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2010-07-294785</ArticleId>
            <ArticleId IdType="pmc">PMC3138694</ArticleId>
            <ArticleId IdType="pubmed">21596854</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
